Archi Patel, PA
Physician Assistant · Lewistown, PANPI 1891394714
Payments from drug & device makers
Across 611 payments — averaging $15.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$1K
- Alkermes, Inc.$974
- Johnson & Johnson$896
- AbbVie$812
- Otsuka America Pharmaceutical, Inc.$774
- Teva Pharmaceuticals USA, Inc.$698
- plus $4K from 26 others
What the payments were for
- Food & beverage$9,12398%
- Education$1562%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 65 | $1,140 |
| Alkermes, Inc. | 56 | $974 |
| Johnson & Johnson | 68 | $896 |
| AbbVie | 55 | $812 |
| Otsuka America Pharmaceutical, Inc. | 49 | $774 |
| Teva Pharmaceuticals USA, Inc. | 51 | $698 |
| Lundbeck LLC | 50 | $572 |
| Neurocrine Biosciences, Inc. | 32 | $452 |
| Bausch Health US, LLC | 20 | $363 |
| Vanda Pharmaceuticals Inc. | 25 | $346 |
| Takeda Pharmaceuticals U.S.A., Inc. | 21 | $319 |
| Almatica Pharma LLC | 11 | $203 |
| Axsome Therapeutics, Inc. | 9 | $182 |
| Neos Therapeutics, LP | 12 | $146 |
| Eisai Inc. | 8 | $140 |
| Merck | 9 | $136 |
| Corium, LLC | 14 | $133 |
| Novo Nordisk | 8 | $116 |
| Sunovion Pharmaceuticals Inc. | 8 | $114 |
| Indivior Inc. | 5 | $99 |
| Noven Therapeutics, LLC | 4 | $80 |
| Sage Therapeutics, LLC | 4 | $79 |
| Biogen | 4 | $71 |
| E.r. Squibb & Sons, L.L.C. | 4 | $66 |
| Ironshore Pharmaceuticals Inc. | 1 | $62 |
| Idorsia Pharmaceuticals US Inc | 4 | $59 |
| Supernus Pharmaceuticals, Inc. | 4 | $59 |
| Acadia Pharmaceuticals Inc | 3 | $54 |
| Avanir Pharmaceuticals, Inc. | 2 | $47 |
| Jazz Pharmaceuticals Inc. | 2 | $39 |
| OWP Pharmaceuticals, Inc. | 2 | $32 |
| Bioxcel Therapeutics, Inc. | 1 | $17 |
How this compares
$9,280 in reported general payments places this provider in the 95th percentile of 6,643 physician assistant providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VraylarCariprazine Hcl | 74 | $102,363 |
| RexultiBrexpiprazole | 59 | $86,533 |
| NuplazidPimavanserin Tartrate | 13 | $64,970 |
| CaplytaLumateperone Tosylate | 21 | $34,410 |
| TrintellixVortioxetine Hydrobromide | 58 | $26,361 |
| AuvelityDextromethorphan Hbr/Bupropion | 24 | $23,602 |
| AbilifyAripiprazole | 11 | $12,635 |
| Bupropion XlBupropion Hcl | 55 | $5,034 |
| Divalproex Sodium ErDivalproex Sodium | 33 | $4,355 |
| Aripiprazole | 90 | $3,990 |
| Vilazodone Hcl | 53 | $3,960 |
| Doxepin Hcl | 65 | $2,256 |
| Clonazepam | 293 | $2,099 |
| Duloxetine Hcl | 103 | $2,057 |
| Buspirone Hcl | 126 | $1,606 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieVraylar | $812 | $102,36374 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $774 | $86,53359 claims |
| Acadia Pharmaceuticals IncNuplazid | $54 | $64,97013 claims |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta | $1,140 | $34,41021 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $319 | $26,36158 claims |
| Axsome Therapeutics, Inc.Auvelity | $182 | $23,60224 claims |
| E.r. Squibb & Sons, L.L.C.Abilify | $66 | $12,63511 claims |
| Almatica Pharma LLCSertraline Hcl | $203 | $1,408156 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 6,643 physician assistant providers in Pennsylvania.
Other physician assistant in Lewistown
- Jonathan HsuLewistown$24K
- Erin CrownState College$1.5M
- Tricia BootsCranberry Twp$313K
- Melissa FerrariPhiladelphia$223K
- Jason OberdickWexford$206K
- Justine RobertsMurrysville$173K
- Allison BoydErie$163K
- Joshua TrbovichWashington$144K
- Daniel TelegaErie$124K
- Alvin KingcadePhiladelphia$101K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.